Whitepaper
Patient-Friendly Studies: Gaining Effective Input Along the Drug-Development Continuum
One of a series of live panels recorded at the WCG Patient Advocacy Forums in Washington D.C. in October, 2019.
How do we make clinical studies more patient-centric? What does “patient-centric” even mean?
Steven Taylor, president and CEO of the Sjogren’s Foundation and Ellen Wagner of Parent Project Muscular Dystrophy (PPMD)—and the parent of a son with Duchenne Muscular Dystrophy (DMD)—shared their insights into how patients and advocates can amplify their voices and provide meaningful input into clinical trials. Danya Kaye, director of business development, R&D and innovation at Inspire, led the conversation.
Click the slides above, or download the PDF to read insights on this topic from patients, patient advocates, and industry leaders.
Speak With Our Experts
